Ae Wealth Management LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Ae Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$1.5 - $9.38 $123,463 - $772,058	-82,309 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$4.79 - $8.39 $34,301 - $60,080	-7,161 Reduced 8.0%	82,309 $691,000
Q1 2020 May 07, 2020	SELL	$3.44 - $7.21 $40,282 - $84,429	-11,710 Reduced 11.57%	89,470 $469,000
Q4 2019 Jan 15, 2020	SELL	$4.29 - $5.64 $21,879 - $28,764	-5,100 Reduced 4.8%	101,180 $552,000
Q3 2019 Nov 05, 2019	SELL	$4.87 - $7.08 $13,046 - $18,967	-2,679 Reduced 2.46%	106,280 $518,000
Q2 2019 Jul 22, 2019	BUY	$6.6 - $7.8 $719,129 - $849,880	108,959 New	108,959 $755,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $720M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.